PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin.\', \'School of Data Science, City University of Hong Kong, Hong Kong.\', \'Laboratory of Cardiovascular Physiology, Li Ka Shing Institute of Health Sciences.\', \'School of Life Sciences, The Chinese University of Hong Kong, Hong Kong.\', \'Department of Cardiology, The First People\'s Hospital of Changzhou, The Third Affiliated Hospital of Soochow University, Changzhou, Jiangsu.\', \'Institute of Automation, Chinese Academy of Sciences, Beijing.\', \'Emergency Medicine Unit, Li Ka Shing Faculty of Medicine.\', \'Department of Pharmacology and Pharmacy.\', \'Division of Clinical Pharmacology and Therapeutics, Department of Medicine, The University of Hong Kong, Pokfulam, Hong Kong, China.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1097/HJH.0000000000002866
?:hasPublicationType
?:journal
  • Journal of hypertension
is ?:pmid of
?:pmid
?:pmid
  • 34188006
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.733
?:rankingScore_hIndex
  • 159
?:title
  • Relationship between angiotensin-converting enzyme inhibitors or angiotensin receptor blockers and COVID-19 incidence or severe disease.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all